Martin Filipits

Martin Filipits

UNVERIFIED PROFILE

Are you Martin Filipits?   Register this Author

Register author
Martin Filipits

Martin Filipits

Publications by authors named "Martin Filipits"

Are you Martin Filipits?   Register this Author

94Publications

2776Reads

30Profile Views

Beyond tissue biopsy: a diagnostic framework to address tumor heterogeneity in lung cancer.

Curr Opin Oncol 2020 Jan;32(1):68-77

Department of Biomedical Imaging and Image-Guided Therapy Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000598DOI Listing
January 2020

From crizotinib to lorlatinib: continuous improvement in precision treatment of ALK-positive non-small cell lung cancer.

ESMO Open 2019 8;4(5):e000548. Epub 2019 Sep 8.

Internal Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2019-000548DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735665PMC
September 2019

EGFR Mutations in Cell-free Plasma DNA from Patients with Advanced Lung Adenocarcinoma: Improved Detection by Droplet Digital PCR.

Target Oncol 2019 04;14(2):197-203

Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8a, 1090, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-019-00623-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453866PMC
April 2019

Adjuvant Therapy in Patients With Completely Resected Non-small-cell Lung Cancer: Current Status and Perspectives.

Clin Lung Cancer 2019 01 24;20(1):1-6. Epub 2018 Sep 24.

Department of Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15257304183026
Publisher Site
http://dx.doi.org/10.1016/j.cllc.2018.09.016DOI Listing
January 2019

PD-1 and PD-L1 Protein Expression Predict Survival in Completely Resected Lung Adenocarcinoma.

Clin Lung Cancer 2018 11 22;19(6):e957-e963. Epub 2018 Aug 22.

Institute of Cancer Research, Medical University of Vienna, Vienna, Austria; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.08.014DOI Listing
November 2018

Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLC.

J Thorac Oncol 2018 06 2;13(6):821-830. Epub 2018 Mar 2.

Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical Center of Vienna, Vienna, Austria. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864183016
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2018.02.014DOI Listing
June 2018

Gamma Knife Radiosurgery in Recurrent Glioblastoma.

Stereotact Funct Neurosurg 2016 8;94(4):265-272. Epub 2016 Oct 8.

Department of Neurosurgery, Medical University Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000448924DOI Listing
September 2017

Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain.

Neuro Oncol 2017 Sep;19(9):1183-1194

Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Austria; Comprehensive Cancer Center, Medical University of Vienna, Austria; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Austria; Neuromed Campus, Kepler University Hospital, Linz, Austria; Institute of Neurology, Medical University of Vienna, Austria; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Pediatric Oncology, Hematology and Immunology, University Hospital Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Neuropathology, University Hospital Heidelberg, Germany; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Neurosurgery, Medical University of Vienna, Austria; Department of Radiotherapy, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nox027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570194PMC
September 2017

Pooled Analysis of the Prognostic and Predictive Effects of TP53 Comutation Status Combined With KRAS or EGFR Mutation in Early-Stage Resected Non-Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy.

J Clin Oncol 2017 Jun 28;35(18):2018-2027. Epub 2017 Apr 28.

Frances A. Shepherd and Ming-Sound Tsao, Princess Margaret Cancer Centre; University of Toronto, Toronto; Lesley Seymour, Queen's University, Kingston, Ontario, Canada; Benjamin Lacas, Gwénaël Le Teuff, Jean-Pierre Pignon, Thierry Le Chevalier, and Jean-Charles Soria, Institut Gustave-Roussy; Benjamin Lacas, Gwénaël Le Teuff, Jean-Pierre Pignon, Thierry Le Chevalier, and Jean-Charles Soria, University Paris XI, Paris; Pierre Hainaut, International Agency for Research on Cancer, Lyon; Jean-Yves Douillard, R Gauducheau, St Herblain; Elizabeth Brambilla, Inserm U823, Institut Albert Bonniot, Département de Pathologie CHU, Albert Michallon University Joseph Fourrier, Grenoble, France; Pasi A. Jänne, Dana-Farber Cancer Institute, Boston, MA; Stephen Graziano, State University of New York Upstate Medical University, Syracuse, NY; Robert Kratzke, University of Minnesota Medical School, Minneapolis, MN; and Robert Pirker and Martin Filipits, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.2893DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075828PMC
June 2017

Prognostic and Predictive Effect of TP53 Mutations in Patients with Non-Small Cell Lung Cancer from Adjuvant Cisplatin-Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis.

J Thorac Oncol 2016 06 17;11(6):850-61. Epub 2016 Feb 17.

International Agency for Research on Cancer, Lyon, France; Department of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada; Department of Pathology, Centre Hospitalier Universitaire, Grenoble, France; International Prevention Research Institute, Lyon, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.02.002DOI Listing
June 2016

Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer.

J Clin Oncol 2016 Apr 1;34(11):1223-30. Epub 2016 Feb 1.

Elisabeth Brambilla and Sylvie Lantuejoul, Institut Albert Bonniot-Institut National de la Santé et de la Recherche Médicale U823; and Centre Hospitalier Universitaire Albert Michallon, Grenoble; Gwénaël Le Teuff, Sophie Marguet, Ariane Dunant, Thierry Le Chevalier, and Jean-Charles Soria, Institut Gustave Roussy, Villejuif; Gwénaël Le Teuff, Sophie Marguet, Ariane Dunant, Thierry Le Chevalier, and Jean-Charles Soria, Université Paris-Sud, Orsay; Gwénaël Le Teuff, Université Paris-Saclay, Saint-Aubin; Jean-Yves Douillard, Centre René Gauducheau Institut de Cancerologie de l'Ouest, Saint-Herblain, France; Stephen Graziano, State University of New York Upstate Medical University, Syracuse, NY; Robert Pirker and Martin Filipits, Medical University of Vienna, Vienna; Helmut Popper, Medical University of Graz, Graz, Austria; Rafael Rosell, Catalan Institute of Oncology, Barcelona, Spain; Robert Kratzke, University of Minnesota, Minneapolis, MN; Frances A. Shepherd and Ming Sound Tsao, Princess Margaret Cancer Centre; Frances A. Shepherd and Ming Sound Tsao, University of Toronto, Toronto; and Lesley Seymour, Queen's University, Kingston, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.0970DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872323PMC
April 2016

The potential of liquid biopsies.

Curr Opin Oncol 2016 Mar;28(2):130-4

Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000267DOI Listing
March 2016

Personalized treatment of advanced non-small-cell lung cancer in routine clinical practice.

Cancer Metastasis Rev 2016 Mar;35(1):141-50

Department of Medicine I, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10555-016-9612-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821865PMC
March 2016

Alectinib in RET-rearranged non-small cell lung cancer-Another progress in precision medicine?

Transl Lung Cancer Res 2015 Dec;4(6):797-800

Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2015.03.08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700226PMC
December 2015

Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma.

Neuro Oncol 2015 Aug 29;17(8):1064-75. Epub 2014 Oct 29.

Institute of Neurology, Medical University of Vienna, Vienna, Austria (A.S.B., G.R., A.W., J.A.H.); Department of Medicine I, Medical University of Vienna, Vienna, Austria (A.S.B., O.R., M.F., A.B., C.C.Z., C.M., M.P.); Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria (A.S.B., B.K., G.W., O.R., G.R., A.W., K.D., M.F., A.B., C.C.Z., C.M., J.A.H., M.P.); Department of Neurosurgery, Medical University of Vienna, Vienna, Austria (B.K., G.W.); Department of Radiotherapy, Medical University of Vienna, Vienna, Austria (K.D.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Laboratory of Brain Tumor Biology and Genetics, Service of Neurosurgery, Department of Clinical Neurosciences, University Hospital Lausanne (CHUV), Lausanne, Switzerland (S.K., M.E.H.); Neurology Clinic and National Center for Tumor Disease, University of Heidelberg, Heidelberg, Germany (W.W.); Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany (W.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou307DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490866PMC
August 2015

Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells.

Int J Cancer 2015 May 3;136(9):2078-90. Epub 2014 Nov 3.

Signaling Networks Program, Division of Oncology, Department of Medicine I, Medical University Vienna, Vienna, Austria; Comprehensive Cancer Center, Medical University Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.29261DOI Listing
May 2015

Prediction of late distant recurrence after 5 years of endocrine treatment: a combined analysis of patients from the Austrian breast and colorectal cancer study group 8 and arimidex, tamoxifen alone or in combination randomized trials using the PAM50 risk of recurrence score.

J Clin Oncol 2015 Mar 20;33(8):916-22. Epub 2014 Oct 20.

Ivana Sestak, Jack Cuzick, Queen Mary University; Mitch Dowsett, Elena Lopez-Knowles, Royal Marsden Hospital, London, United Kingdom; Martin Filipits, Peter Dubsky, Michael Gnant, Medical University of Vienna; Christian Fesl, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria; John Wayne Cowens, Sean Ferree, NanoString Technologies, Seattle, WA; and Carl Shaper, MyRAQA, Redwood Shores, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.6894DOI Listing
March 2015

PYK2 sustains endosomal-derived receptor signalling and enhances epithelial-to-mesenchymal transition.

Nat Commun 2015 Feb 4;6:6064. Epub 2015 Feb 4.

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms7064DOI Listing
February 2015

Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer.

Mol Oncol 2014 May 15;8(3):555-64. Epub 2014 Jan 15.

University of Strathclyde School of Global Public Health at iPRI, International Prevention Research Institute, Lyon, France; Institut Albert Bonniot, Institut National de la Santé et de la Recherche Médicale U 823, Grenoble, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2013.12.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528648PMC
May 2014

Late recurrences in early breast cancer: for whom and how long is endocrine therapy beneficial?

Breast Care (Basel) 2014 May;9(2):97-100

Department of Surgery, Comprehensive Cancer Center, Medical University Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000362482DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038313PMC
May 2014

Clinical Neuropathology practice news 1-2014: pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma.

Clin Neuropathol 2014 Jan-Feb;33(1):6-14

Department of Medicine I, Medical University of Vienna, Vienna, Division of Pathology, Medical University of Innsbruck, Innsbruck, Comprehensive Cancer Center - CNS Tumors Unit (CCC-CNS), Medical University of Vienna, Vienna, Molecular Diagnostics, Austrian Institute of Technology, Department of Radiotherapy, Department of Neurosurgery, and Institute of Neurology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891253PMC
http://dx.doi.org/10.5414/np300730DOI Listing
April 2014

New developments in the treatment of squamous cell lung cancer.

Authors:
Martin Filipits

Curr Opin Oncol 2014 Mar;26(2):152-8

Department of Medicine I, Institute of Cancer Research, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000049DOI Listing
March 2014

The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer.

Clin Cancer Res 2014 Mar 11;20(5):1298-305. Epub 2014 Feb 11.

Authors' Affiliations: Departments of Medicine I, Pathology, and Surgery; Department of Obstetrics and Gynecology, Comprehensive Cancer Center Vienna, Medical University of Vienna; Austrian Breast and Colorectal Cancer Study Group, Vienna; Departments of Internal Medicine III and Pathology, Paracelsus Private Medical University, Salzburg; Departments of Internal Medicine and Pathology, Medical University of Graz, Graz; Departments of Pathology and Surgery, Sisters of Charity Hospital and Cancer Center, Linz; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck; Department of Surgery, General Hospital Baden, Baden, Austria; Myraqa, Redwood Shores, California; NanoString Technologies, Seattle, Washington; and British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1845DOI Listing
March 2014

Low protein expression of MET in ER-positive and HER2-positive breast cancer.

Anticancer Res 2014 Mar;34(3):1227-31

Associate Professor; Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://ar.iiarjournals.org/content/34/3/1227.full.pdf
Web Search
March 2014

Pertuzumab in breast cancer: a systematic review.

Clin Breast Cancer 2013 Oct 27;13(5):315-24. Epub 2013 Jun 27.

Comprehensive Cancer Center Vienna, Department of Medicine I/Division of Oncology, Medical University of Vienna, Austria; Department of Clinical Therapeutics, "Alexandra" Hospital, Medical School, University of Athens, Greece. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2013.05.002DOI Listing
October 2013

UDP-glucuronosyltransferase 2B17 genotype and the risk of lung cancer among Austrian Caucasians.

Cancer Epidemiol 2013 Oct 11;37(5):625-8. Epub 2013 Jul 11.

Department of Medicine I, Division of Hematology and Hemostaseology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canep.2013.06.004DOI Listing
October 2013

Molecularly targeted therapies in metastatic pancreatic cancer: a systematic review.

Pancreas 2013 Jul;42(5):760-73

Comprehensive Cancer Center Vienna, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0b013e31827aedefDOI Listing
July 2013

mTOR inhibitors in breast cancer: a systematic review.

Gynecol Oncol 2012 Dec 9;127(3):662-72. Epub 2012 Sep 9.

Comprehensive Cancer Center Vienna, Department of Medicine I/Division of Oncology, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.08.040DOI Listing
December 2012

[Early staging in non-small cell lung cancer].

Onkologie 2012 15;35 Suppl 3:6-9. Epub 2012 May 15.

Innere Klinik - Tumorforschung, Westdeutsches Tumorzentrum, Universitätsklinikum Essen, Universität Duisburg-Essen, Essen, Deutschland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000338977DOI Listing
November 2012

Taxanes for ovarian cancer during pregnancy: a systematic review.

Oncology 2012 16;83(4):234-8. Epub 2012 Aug 16.

Comprehensive Cancer Center Vienna, Division of Oncology, Department of Medicine I, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000341351DOI Listing
November 2012

Molecularly targeted therapies in cervical cancer. A systematic review.

Gynecol Oncol 2012 Aug 11;126(2):291-303. Epub 2012 Apr 11.

Comprehensive Cancer Center Vienna, Department of Medicine I/Division of Oncology, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S009082581200259
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2012.04.007DOI Listing
August 2012

Cetuximab in non-small-cell lung cancer.

Transl Lung Cancer Res 2012 Mar;1(1):54-60

Department of Medicine I, Medical University Vienna, 1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.11.01DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367590PMC
March 2012

Predictive markers in the adjuvant therapy of non-small cell lung cancer.

Lung Cancer 2011 Dec 31;74(3):355-63. Epub 2011 Aug 31.

Department of Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2011.06.005DOI Listing
December 2011

Adjuvant sequencing of tamoxifen and anastrozole is superior to tamoxifen alone in postmenopausal women with low proliferating breast cancer.

Clin Cancer Res 2011 Dec 13;17(24):7828-34. Epub 2011 Oct 13.

Departments of Pathology, Surgery, Special Gynecology, and Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-1846DOI Listing
December 2011

Monoclonal antibodies against EGFR in non-small cell lung cancer.

Crit Rev Oncol Hematol 2011 Oct 24;80(1):1-9. Epub 2010 Nov 24.

Department of Medicine I, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2010.10.008DOI Listing
October 2011

MutS homologue 2 and the long-term benefit of adjuvant chemotherapy in lung cancer.

Clin Cancer Res 2010 Feb 9;16(4):1206-15. Epub 2010 Feb 9.

Department of Medicine, Biostatistics and Epidemiology Unit, Translational Research Laboratory, Paris-Sud University, Gustave-Roussy Institute, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-2204DOI Listing
February 2010

Integrating epidermal growth factor receptor-targeted therapies into platinum-based chemotherapy regimens for newly diagnosed non-small-cell lung cancer.

Clin Lung Cancer 2008 ;9 Suppl 3:S109-15

Department of Internal Medicine I, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLC.2008.s.016DOI Listing
December 2009

CDK10 is not a target for aberrant DNA methylation in breast cancer.

Anticancer Res 2009 Oct;29(10):3939-44

Department of Medicine I, Medical University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
October 2009

EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases.

Clin Cancer Res 2009 Jul 7;15(14):4554-60. Epub 2009 Jul 7.

Clinical Institute of Pathology and Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, Vienna A-1090, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-0089DOI Listing
July 2009

Targeted therapies in lung cancer.

Curr Pharm Des 2009 ;15(2):188-206

Department of Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/138161209787002915DOI Listing
March 2009

[Biomarkers - the way towards individualized chemotherapy in non-small cell lung cancer (NSCLC)].

Wien Med Wochenschr 2007 ;157(21-22):554-61

Institut für Krebsforschung, Universitätsklinik für Innere Medizin I, Medizinische Universität Wien, Wien, Osterreich.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10354-007-0483-xDOI Listing
April 2008

Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer.

Breast Cancer Res Treat 2007 Jul 27;103(3):283-91. Epub 2007 Jan 27.

Clinical Division of Oncology, Department of Medicine I, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-006-9377-7DOI Listing
July 2007

E-cadherin and beta-catenin expression in normal, inflamed and cancerous gallbladder tissue.

Anticancer Res 2005 Nov-Dec;25(6B):4249-54

Department of General Surgery, General Hospital, Medical University of Vienna, 1090 Vienna, Austria.

View Article

Download full-text PDF

Source
January 2006

Highly refractory acute myeloid leukemia.

Wien Klin Wochenschr 2004 Aug;116(15-16):561-4

Division of Hematology and Hemostaseology, The University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/bf03217710DOI Listing
August 2004

Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy.

Breast Cancer Res Treat 2003 Sep;81(2):149-57

Department of Pathology, University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/A:1025751631115DOI Listing
September 2003

Low p27Kip1 expression is an independent prognostic factor in gallbladder carcinoma.

Anticancer Res 2003 Jan-Feb;23(1B):675-9

Department of Internal Medicine I, Division of Oncology, University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
April 2003

Expression of cell cycle regulatory proteins in breast carcinomas before and after preoperative chemotherapy.

Breast Cancer Res Treat 2003 Mar;78(1):97-103

Department of Internal Medicine 1, Division of Oncology, University Hospital, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/a:1022165715043DOI Listing
March 2003

Low p27Kip1 expression is an independent adverse prognostic factor in patients with multiple myeloma.

Clin Cancer Res 2003 Feb;9(2):820-6

Department of Medicine I, Clinical Division of Oncology, University of Vienna, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
February 2003

Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma.

Clin Cancer Res 2002 Mar;8(3):729-33

Department of Internal Medicine I, Division of Oncology, University of Vienna, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/8/3/729.full.p
Web Search
March 2002